We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+18.99%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$13.3B
AUM Growth
+$2.87B
(+28%)
Cap. Flow
+$1.1B
Cap. Flow
% of AUM
8.24%
Top 10 Holdings %
Top 10 Hldgs %
20.04%
Holding
2,557
New
285
Increased
1,225
Reduced
862
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$87.9M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$51.9M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$44.1M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$40.8M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$28.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$50.5M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$41.1M |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$28.4M |
| 4 |
Pacer Trendpilot US Large Cap ETF
PTLC
|
+$22.6M |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$18.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.95% |
| 2 | Consumer Discretionary | 4.49% |
| 3 | Healthcare | 4.46% |
| 4 | Financials | 4.28% |
| 5 | Communication Services | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
VanEck Morningstar Wide Moat ETF
MOAT
$12.3B
| $6.57M | 0.05% |
125,827
-13,458
| -10% | -$670K |
|
352
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
| $6.56M | 0.05% |
72,765
+19,786
| +37% | +$1.7M |
|
353
iShares Core Universal USD Bond ETF
IUSB
$43.2B
| $6.56M | 0.05% |
120,742
+25,623
| +27% | +$1.37M |
|
354
Travelers Companies
TRV
$78.1B
| $6.56M | 0.05% |
57,511
+3,035
| +6% | +$320K |
|
355
Automatic Data Processing
ADP
$106B
| $6.55M | 0.05% |
44,023
+164
| +0.4% | +$23.5K |
|
356
ProShares Large Cap Core Plus
CSM
$532M
| $6.54M | 0.05% |
184,400
-2,450
| -1% | -$82.4K |
|
357
Vanguard S&P 500 Growth ETF
VOOG
$27.3B
| $6.52M | 0.05% |
209,400
+23,118
| +12% | +$666K |
|
358
iShares Russell 3000 ETF
IWV
$20.4B
| $6.5M | 0.05% |
36,087
+9,205
| +34% | +$1.56M |
|
359
Sherwin-Williams
SHW
$87.6B
| $6.48M | 0.05% |
33,663
+2,412
| +8% | +$435K |
|
360
Micron Technology
MU
$1.04T
| $6.47M | 0.05% |
125,550
+5,611
| +5% | +$265K |
|
361
Southwest Airlines
LUV
$21.9B
| $6.47M | 0.05% |
189,184
+98,815
| +109% | +$3.14M |
|
362
iShares Core Conservative Allocation ETF
AOK
$793M
| $6.46M | 0.05% |
177,472
+27,323
| +18% | +$967K |
|
363
Invesco Dorsey Wright Momentum ETF
PDP
$1.53B
| $6.41M | 0.05% |
95,230
-15,275
| -14% | -$953K |
|
364
Schwab U.S Small- Cap ETF
SCHA
$23.2B
| $6.4M | 0.05% |
391,812
-42,752
| -10% | -$640K |
|
365
Franklin Short Duration US Government ETF
FTSD
$309M
| $6.38M | 0.05% |
66,605
+50,463
| +313% | +$4.82M |
|
366
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$462M
| $6.37M | 0.05% |
189,311
+12,979
| +7% | +$422K |
|
367
Vertex Pharmaceuticals
VRTX
$134B
| $6.34M | 0.05% |
21,848
+11,228
| +106% | +$3.04M |
|
368
TJX Companies
TJX
$170B
| $6.32M | 0.05% |
125,050
+26,036
| +26% | +$1.31M |
|
369
Zoetis
ZTS
$29.9B
| $6.32M | 0.05% |
46,125
+14,378
| +45% | +$1.88M |
|
370
Invesco S&P SmallCap Low Volatility ETF
XSLV
$248M
| $6.29M | 0.05% |
185,777
-412,336
| -69% | -$13.7M |
|
|
WBA
371
DELISTED
Walgreens Boots Alliance
WBA
| $6.29M | 0.05% |
148,333
+12,737
| +9% | +$541K |
|
372
International Paper
IP
$21.7B
| $6.28M | 0.05% |
188,441
-15,847
| -8% | -$505K |
|
373
Citigroup
C
$232B
| $6.28M | 0.05% |
122,843
+14,928
| +14% | +$708K |
|
374
Invesco Equal Weight 0-30 Year Treasury ETF
GOVI
$1.22B
| $6.25M | 0.05% |
158,742
+65,309
| +70% | +$2.57M |
|
375
Colgate-Palmolive
CL
$73.7B
| $6.23M | 0.05% |
85,024
-3,827
| -4% | -$272K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Cambridge Investment Research Advisors held 2,557 positions worth $13.3B, up 28% from $10.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors deployed $1.1B of net new capital in Q2 2020, opening 285 new positions and adding to 1,225 existing holdings. Its largest new stake was FS KKR Capital Corp. II: 1,991,449 shares worth $25.7M.
By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 8% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $50.5M trimmed.
- Cambridge Investment Research Advisors's largest Q2 2020 buy was FS KKR Capital Corp. II: 1,991,449 shares worth $25.7M.
- Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q2 2020, an estimated $87.9M increase.
- Cambridge Investment Research Advisors's biggest Q2 2020 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $50.5M.
- Cambridge Investment Research Advisors fully exited Raytheon Company in Q2 2020, selling an estimated $7.24M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $13.3B portfolio in Q2 2020.
- Cambridge Investment Research Advisors opened 285 new positions and closed 103 in Q2 2020.
- Cambridge Investment Research Advisors's portfolio value rose 28% quarter-over-quarter to $13.3B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.